NCT00726414View on ClinicalTrials.gov

A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Healthy
Interventions
DRUG

Quinine Sulfate 2 x 324 mg Capsules

Quinine Sulfate (2 x 324 mg capsules) administered after an overnight fast of at least 10 hours.

DRUG

Quinine Sulfate 2 x 324 mg Capsules

Quinine Sulfate (2 x 324 mg capsules) administered 30 minutes after a standardized, high fat breakfast.

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00726414 - A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg | Biotech Hunter | Biotech Hunter